Back to results
US 2009/0269335 A1Published application
Therapeutic agent for prostate cancer
AssigneesKeio University, Chugai Seiyaku Kabushiki Kaisha
InventorsJun Nakashima, Kent Kanao
Life of this patent
Estimating the term…
Abstract
The present inventors investigated the antitumor effects of anti-IL-6 receptor antibodies against prostate cancer. The result showed that the anti-IL-6 receptor antibodies had both in vivo and in vitro antitumor effects against prostate cancer. It was also revealed that the hPM1 antitumor effect is via IL-6 receptor.
Claims13
1-8. (canceled)
A method for treating prostate cancer in a subject, which comprises the step of administering an IL-6 inhibitor to the subject who has developed prostate cancer.
16-22. (canceled)
Dependencies are inferred from the claim text.